(Q73947936)
Statements
Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-alpha2a in patients with HIV. AIDS Clinical Trials Group Study 197 (English)
M Saag
D D Richman
T C Meng
K E Squires
J Holden-Wiltse
1 December 1997